Comparison of Time From Symptom Onset to Oseltamivir Access When Oseltamivir is Prescribed by Pharmacists vs. Physicians and the Impact on Symptoms, Oseltamivir Resistance, and Patient Safety

Trial Profile

Comparison of Time From Symptom Onset to Oseltamivir Access When Oseltamivir is Prescribed by Pharmacists vs. Physicians and the Impact on Symptoms, Oseltamivir Resistance, and Patient Safety

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 Aug 2013

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Acronyms ACCESS
  • Sponsors Roche
  • Most Recent Events

    • 19 Apr 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Nov 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 14 Sep 2012 Planned end date changed from 1 May 2012 to 1 May 2013 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top